🇺🇸 FDA
Patent

US 10888516

Soluble estradiol capsule for vaginal insertion

granted A61KA61K31/565A61K31/57

Quick answer

US patent 10888516 (Soluble estradiol capsule for vaginal insertion) held by Compass Therapeutics LLC expires Mon Jan 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Compass Therapeutics LLC
Grant date
Tue Jan 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/565, A61K31/57, A61K47/10, A61K47/14